Aberdeen Group
INSP icon

Aberdeen Group’s Inspire Medical Systems INSP Stock Holding History

Aberdeen Group’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-358,968
Closed -$16M – 1021
2026
Q2 		$16M Sell
358,968
-118,508
-25% -$5.62M 0.02% 502
2026
Q1 		$24.6M Buy
477,476
+16,575
+4% +$1.16M 0.04% 360
2025
Q4 		$42.5M Buy
460,901
+64,561
+16% +$6.18M 0.07% 248
2025
Q3 		$30M Buy
396,340
+153,238
+63% +$15.5M 0.05% 313
2025
Q2 		$31.5M Buy
243,102
+121,741
+100% +$17.7M 0.05% 299
2025
Q1 		$19.3M Hold
121,361
– – 0.04% 399
2024
Q4 		$22.4M Hold
121,361
– – 0.04% 345
2024
Q3 		$25.6M Buy
121,361
+16,881
+16% +$2.93M 0.05% 334
2024
Q2 		$14M Buy
104,480
+58,519
+127% +$11.1M 0.03% 453
2024
Q1 		$9.9M Hold
45,961
– – 0.02% 548
2023
Q4 		$9.35M Buy
+45,961
New +$7.45M 0.02% 563

Other funds holding INSP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Aberdeen Group's INSP Position: Q3 2026 in Review

Aberdeen Group sold out of Inspire Medical Systems (INSP) in Q3 2026, closing a stake of 358,968 shares — an estimated $16M sold.

Aberdeen Group first reported a position in INSP in Q4 2023 and held it in 11 quarters. The position peaked at $42.5M in Q4 2025. 126 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • Aberdeen Group reported no remaining Inspire Medical Systems position as of Q3 2026 after selling out during the quarter.
  • Aberdeen Group sold 358,968 Inspire Medical Systems shares in Q3 2026, an estimated $16M.
  • Aberdeen Group first reported a position in Inspire Medical Systems in Q4 2023 and held it in 11 quarters.
  • Aberdeen Group's Inspire Medical Systems position peaked at $42.5M in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.